$NBIO - The company most recently announced that the United States Patent and Trademark Office (the USPTO) issued patent No. 11,492,394 on November 8, 2022, for claims related to the Company's lead candidate Pritumumab.
https://www.marketwatch.com/press-release/fis...2022-11-30